WordNet

want to have; "Id like a beer now!"
a kind of person; "Well not see his like again"; "I cant tolerate people of his ilk" (同)ilk
a similar kind; "dogs, foxes, and the like", "we dont want the likes of you around here" (同)the like, the likes of
equal in amount or value; "like amounts"; "equivalent amounts"; "the same amount"; "gave one six blows and the other a like number"; "the same number" (同)same
resembling or similar; having the same or some of the same characteristics; often used in combination; "suits of like design"; "a limited circle of like minds"; "members of the cat family have like dispositions"; "as like as two peas in a pod"; "doglike devotion"; "a dreamlike quality" (同)similar
be fond of; "I like my nephews"
feel about or towards; consider, evaluate, or regard; "How did you like the Presidents speech last night?"
find enjoyable or agreeable; "I like jogging"; "She likes to read Russian novels"
(of volcanos) pouring out fumes or lava (or a deposit so formed) (同)eructation, extravasation
symptom consisting of a breaking out and becoming visible
the emergence of a tooth as it breaks through the gum
a feeling of pleasure and enjoyment; "Ive always had a liking for reading"; "she developed a liking for gin"
an inflammatory disease involving the sebaceous glands of the skin; characterized by papules or pustules or comedones
(of complexion) blemished by imperfections of the skin (同)pimpled, pimply, pustulate

PrepTutorEJDIC

…‘を'『好む』,‘が'好きである / 《しばしば否定文で,またwould,《英》shouldと共に用いて》…‘を'望む,…したい / 『好む』;望む / 《複数形で》好み,好きな事
(外観・性質などが)…『に似た』,のような / (やり方,程度などが)…『と同じように』 / …『らしい』,にふさわいし / 《おもに話》たとえば…のような / 《名詞の前にのみ用いて》(性質・外観などが)同じの,(数量が)等しい / 《補語にのみ用いて》似ている,そっくりで / たぶん,おそらく(probably) / (…に)似た人(物),(…と)同等の人(物),匹敵する人(物)《+『of』+『名』》 / …のように / あたかも…のように
(病気・災害などの)『突発』,(戦争などの)勃(ぼっ)発;(怒り・笑いの)爆発《+『of』+『名』》 / (溶岩・熱湯などの)『噴出』;(火山の)『噴出』;(火山の)『噴火』《+『of』+『名』》;(火山・間欠泉などからの)噴出物
(…の)『好み』,趣味《+『for』(『to』)+『名』》
にきび(pimple)

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

1. 上皮成長因子受容体（EGFR）阻害剤投与に続発するざ瘡様発疹 acneiform eruption secondary to epidermal growth factor receptor egfr inhibitors
2. 尋常性ざ瘡の病因、臨床症状、および診断 pathogenesis clinical manifestations and diagnosis of acne vulgaris
3. 薬疹 drug eruptions
4. 分子標的剤およびその他の生物製剤を用いた癌治療による皮膚合併症 cutaneous complications of molecularly targeted therapy and other biologic agents used for cancer therapy
5. 項部のケロイド性ざ瘡 acne keloidalis nuchae

Randomized double-blind trial of prophylactic topical Evozac(®) Calming Skin Spray for gefitinib-associated acne-like eruption.

Wang Y1, Yang Y1, Xu J1, Yu J1, Liu X1, Gao R1, Zhang L1.
OncoTargets and therapy.Onco Targets Ther.2014 Jul 10;7:1261-6. doi: 10.2147/OTT.S65961. eCollection 2014.
BACKGROUND: "Gefitinib" is a first-generation epidermal growth factor receptor tyrosine-kinase inhibitor. More than half of patients receiving gefitinib develop acne-like eruption. Evozac(®) Calming Skin Spray (Evaux Laboratoires, Évaux-les-Bains, France) is made of Évaux thermal spring water and
PMID 25031540

Phase II study of the combination of cetuximab and weekly paclitaxel in the first-line treatment of patients with recurrent and/or metastatic squamous cell carcinoma of head and neck.

Hitt R1, Irigoyen A, Cortes-Funes H, Grau JJ, García-Sáenz JA, Cruz-Hernandez JJ; Spanish Head and Neck Cancer Cooperative Group (TTCC).
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO.Ann Oncol.2012 Apr;23(4):1016-22. doi: 10.1093/annonc/mdr367. Epub 2011 Aug 23.
BACKGROUND: The efficacy and safety of a novel combination of weekly paclitaxel and the epidermal growth factor receptor (EGFR) monoclonal antibody cetuximab for the first-line treatment of recurrent and/or metastatic squamous cell carcinoma of the head and neck were investigated.PATIENTS AND METHOD
PMID 21865152

Short-term outcomes of cetuximab combined with standard chemotherapy as first line setting for Chinese patients with non-small cell lung cancer: a report of 12 cases.

Xia LP1, Qiu HJ, Chen XX, Hu PL, Guo GF, Wang F, Zhou FF, He WZ, Zhang B, Zhang L.
Medical oncology (Northwood, London, England).Med Oncol.2011 Dec;28 Suppl 1:S570-6. doi: 10.1007/s12032-010-9709-7. Epub 2010 Oct 22.
Cetuximab combined with chemotherapy has been used to treat Non-small cell lung cancer (NSCLC) in recent years, however, the data from China was rare. This study was to summarize our experiences in treating NSCLC patients with cetuximab in the first line setting. From October 1st 2006 to Jun 30th 20
PMID 20967514

川崎有亮,寺嶋宏明,上田修吾,福永明子,八木田正人
日本臨床外科学会雑誌 74(6), 1547-1551, 2013
症例はtrisomy8陽性骨髄異形成症候群とSjögren症候群で当院加療中の32歳の女性．右下腹部痛と発熱を主訴に緊急入院し，絶食と抗生剤加療で症状は改善したが，入院9日目に腹痛が再燃，腹部CT検査で消化管穿孔に伴う汎発性腹膜炎と診断された．緊急開腹術で上行結腸および終末回腸の穿孔と判明し，結腸右半切除+回腸人工肛門造設術を施行した．回盲部病変は病理学的診断で非特異的潰瘍であり，口腔内アフタ性潰 …
NAID 130004518729

甲斐裕美子,中井菜美,井上千津子,明石雄策,梁尚志
皮膚の科学 3(2), 170-174, 2004
ゲフィチニブ(イレッサ<SUP>®</SUP>)は，強力かつ選択的な上皮成長因子受容体(EGFR)チロシンキナーゼ阻害薬で，2002年7月，世界に先駆けわが国で承認され，手術不能あるいは再発の非小細胞肺癌の治療に用いられている。当院では，2002年7月から2003年9月までの1年2ヵ月間に，合計32例に投与され，そのうち17例(53%)に皮膚病変の出現を認めた。それら皮膚病 …
NAID 130004934350

鈴木弘美,籏持淳,橋壁道雄,山崎雙次,田村元彦,石濱洋美,三好新一郎
西日本皮膚科 66(6), 599-601, 2004
肺癌治療のために選択的上皮成長因子受容体チロシンキナーゼ阻害剤であるゲフィチニブ(イレッサ®)を1日あたり250mg内服投与中に, ざ瘡様皮疹を生じた6例を経験したので報告する。程度は様々であったが全例ゲフィチニブ内服中に毛孔一致性粟粒大の紅色小丘疹, 小膿疱が主に顔面, 前胸部, 背部などに出現した。6例中1例は皮膚生検を施行し, 病理組織学的に真皮上層の毛嚢周囲にリンパ球を主体とした炎症性細胞 …
NAID 130004831482